Tessera Therapeutics
Gene Editing
4 open rolesGene EditingSomerville, United States256 employees$734M raisedEst. 2018
Flagship Pioneering
Abu Dhabi Investment Authority
Alaska Permanent Fund Corporation
SoftBank Vision Fund 2
T. Rowe Price
Temasek
About Tessera Therapeutics
- Tessera Therapeutics is an early-stage biotechnology company pioneering Gene Writing™, a novel gene-editing technology.
- It aims to cure rare genetic diseases that current gene therapies cannot address by making permanent alterations to the human genome.
Tessera Therapeutics is listed on Rocketlist with 4 active roles. The company is categorized as Gene Editing in BioTech. Tessera Therapeutics is at Series D+ stage, with a B2B business model, headquartered in Somerville, United States. Tessera Therapeutics was founded in 2018 and has 256 employees. Tessera Therapeutics has raised $734M. Active roles are refreshed daily from public hiring sources.
Open roles at Tessera Therapeutics (4)
Senior Scientist, Computational Biology - Contract
Tessera Therapeutics · Somerville, United States · Senior
Data & AI
Scientist I/II, Bioanalytical (LC-MS)
Tessera Therapeutics · Somerville, United States · $109,000 - $143,000 · Mid
Data & AI